Show simple item record

dc.contributor.authorRojas, B
dc.contributor.authorMcGowan, DR
dc.contributor.authorGuy, MJ
dc.contributor.authorTipping, J
dc.contributor.authorAldridge, M
dc.contributor.authorGear, J
dc.date.accessioned2021-07-26T14:13:35Z
dc.date.available2021-07-26T14:13:35Z
dc.date.issued2019-07
dc.identifier.citationNuclear medicine communications, 2019, 40 (7), pp. 657 - 661
dc.identifier.issn0143-3636
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/4695
dc.identifier.eissn1473-5628en_US
dc.identifier.doi10.1097/mnm.0000000000001020en_US
dc.formatPrint
dc.format.extent657 - 661
dc.languageeng
dc.language.isoeng
dc.subjectHumans
dc.subjectRadiotherapy
dc.subjectRadiometry
dc.subjectAdult
dc.subjectChild
dc.subjectClinical Trials as Topic
dc.subjectSurveys and Questionnaires
dc.subjectUnited Kingdom
dc.titleEighty per cent more patients in 10 years of UK molecular radiotherapy: Internal Dosimetry Users Group survey results from 2007 to 2017.
dc.typeJournal Article
rioxxterms.versionofrecord10.1097/mnm.0000000000001020
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2019-07en_US
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfNuclear medicine communications
pubs.issue7
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR
pubs.publication-statusPublished
pubs.volume40en_US
pubs.embargo.termsNot known
dc.contributor.icrauthorGear, Jonathanen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record